Public Statements

Office
State
Issue
Limit Result To
Keyword Search

6/15/17 Senator Baldwin to Health Secretary Price at Hearing: Why Do You Want to Take Away Coverage and Increase Costs for Wisconsinites Struggling with Opioid Addiction? Sen. Tammy Baldwin 6/13/17 Manchin Questions Deputy AG Rod Rosenstein on Drug Court Funding for West Virginia Sen. Joe Manchin 6/13/17 Senator Baldwin Continues Push for Bipartisan Reform to Address Skyrocketing Prescription Drug Prices at Hearing Sen. Tammy Baldwin 6/09/17 Manchin Applauds FDA Decision to Remove Opioid Pain Medication from Market Sen. Joe Manchin 6/08/17 Hearing of the Senate Banking, Housing and Urban Affairs Committee - Opening Statement of Sen. Brown, Hearing on Fostering Economic Growth: The Role of Financial Institutions in Local Communities Sen. Sherrod Brown 6/06/17 Rothfus Statement on the U.S.-Mexico Interparliamentary Group Meeting Rep. Keith Rothfus 6/05/17 Rothfus Participates in U.S.-Mexico Interparliamentary Group Rep. Keith Rothfus 6/02/17 Following McCaskill Request, Department of Justice Inspector General to Investigate Opioid Enforcement Sen. Claire McCaskill 6/02/17 Barletta Announces Availability of Grants to Help Local Communities Fight Opioid Epidemic Rep. Louis Barletta 6/01/17 Letter to the Hon. Chris Christie, John Carney, and Tom Wolf, Governors of New Jersey, Delaware, and Pennsylvania - Urging Governors to Expedite Drug Information Sharing Rep. Donald Norcross 6/01/17 Letter to the Hon. Chris Christie, John Carney, and Tom Wolf, Governors of New Jersey, Delaware, and Pennsylvania - Urging Governors to Expedite Drug Information Sharing Rep. Lisa Rochester 6/01/17 Senator Hassan Cosponsors Bipartisan Legislation to Require Use of Prescription Drug Monitoring Programs Sen. Margaret Wood Hassan 6/01/17 Letter to the Hon. Chris Christie, John Carney, and Tom Wolf, Governors of New Jersey, Delaware, and Pennsylvania - Urging Governors to Expedite Drug Information Sharing Rep. Patrick Meehan 5/31/17 McCaskill Targets Opioid Shipments from China During Senate Hearing Sen. Claire McCaskill 5/31/17 Fitzpatrick Named Vice Chair of Bipartisan Heroin Task Force Rep. Brian Fitzpatrick 5/31/17 Fitzpatrick Named Vice Chair of Bipartisan Heroin Task Force Rep. Ann Kuster 5/31/17 Fitzpatrick Named Vice Chair of Bipartisan Heroin Task Force Rep. Donald Norcross 5/26/17 Buchanan Honored as Health Care Champion Rep. Vern Buchanan 5/25/17 Hearing of the Permanent Subcommittee On Investigations Subcommittee of the Senate Homeland Security and Governmental Affairs Committee - Opening Statement of Sen. Carper, Hearing on Stopping the Shipment of Synthetic Opioids: Oversight of U.S. Strategy to Combat Illicit Drugs Sen. Thomas Carper 5/25/17 Press Release: Foster Reintroduces Bipartisan Legislation to Increase Treatment for Opioid and Heroin Addiction Rep. Bill Foster 5/25/17 Whitehouse Brings Stories of RI's Opioid Crisis to Senate Floor Sen. Sheldon Whitehouse 5/25/17 Portman on Yahoo News: "Russia's Behavior Should Not Be Rewarded" Sen. Robert Portman 5/25/17 Hearing of the Permanent Subcommittee On Investigations Subcommittee of the Senate Homeland Security and Governmental Affairs Committee - Opening Statement of Sen. Portman, Hearing on Stopping the Shipment of Synthetic Opioids: Oversight of U.S. Strategy to Combat Illicit Drugs Sen. Robert Portman 5/25/17 Manchin Leads Colleagues in Discussion of Opioid Epidemic on the Senate Floor Sen. Joe Manchin 5/25/17 Myth vs. Fact: Debunking False Postal Service Claims about the STOP Act Sen. Robert Portman 5/24/17 U.S. Senator Tammy Baldwin Statement on CBO Score of House-Passed Health Care Bill Sen. Tammy Baldwin 5/24/17 Ahead of Tomorrow's Opioid Trafficking Hearing, Portman Makes the Case for the STOP Act on Fox News Sen. Robert Portman 5/24/17 Reaction Of Senator Patrick Leahy To The Joint Review Of The Inspectors General Of The Departments Of Justice And State On Three Deadly Force Incidents In Honduras Sen. Patrick Leahy 5/24/17 Hearing of the House Ways and Means Committee - Opening Statement of Rep. Richard Neal, Markup of GOP Health Care Legislation Rep. Richard Neal 5/23/17 Capito Statement on ONDCP Funding in President's Budget Proposal Sen. Shelley Capito 5/23/17 After Pressure from McCaskill, Administration Backs Off Proposal to Eliminate Office of National Drug Control Policy Sen. Claire McCaskill 5/23/17 Capito Applauds New FDA Opioid Policy Steering Committee Sen. Shelley Capito 5/23/17 Manchin Statement on the President's 2018 Budget Proposal Sen. Joe Manchin 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. David Joyce 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Marcia Fudge 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Stephen Cohen 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Richard Larsen 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Timothy Ryan 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Filemon Vela 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Elijah Cummings 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Ben Lujan 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Carol Shea-Porter 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Frank Pallone 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. André Carson 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Bobby Rush 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Jimmy Panetta 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. S. Krishnamoorthi 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. John Katko 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Bonnie Watson Coleman 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Pramila Jayapal 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Keith Rothfus 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Anna Eshoo 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Eleanor Norton 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. David Scott 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Patrick Meehan 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Brian Fitzpatrick 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Bill Johnson 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Aston McEachin 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Joseph Kennedy 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Vicente Gonzalez 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Steve Stivers 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Donald Payne 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. James McGovern 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. John Yarmuth 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Marcy Kaptur 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Derek Kilmer 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Evan Jenkins 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Terri Sewell 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Brad Wenstrup 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Sander Levin 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Joseph Courtney 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Peter DeFazio 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Linda Sánchez 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Chellie Pingree 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Sean Maloney 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Nicola Tsongas 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Paul Tonko 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Suzanne Bonamici 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Dwight Evans 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Stephanie Murphy 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Louise Slaughter 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. John Delaney 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Mike Quigley 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Brenda Lawrence 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. David Roe 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Jamin Raskin 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Timothy Walberg 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. John Faso 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Danny Davis 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Lucille Roybal-Allard 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Ann Kuster 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Val Demings 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. David McKinley 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Cheri Bustos 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Anthony Brown 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Daniel Donovan 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Michelle Lujan Grisham 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Adam Smith 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. Peter Welch 5/19/17 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. David Cicilline

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.